MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
16.29
-0.06 (-0.37%)
Aug 18, 2026, 1:12 PM EDT - Market open
MLTX Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 477.91 | 334.52 | 180.43 | 451.17 | 39.51 | 8.04 |
Short-Term Investments | 59.13 | 59.45 | 267.6 | 59.84 | 32.61 | - |
Cash & Short-Term Investments | 537.03 | 393.97 | 448.03 | 511.01 | 72.11 | 8.04 |
Cash Growth | 26.33% | -12.07% | -12.32% | 608.60% | 797.08% | - |
Other Receivables | 6.56 | 4.87 | 2.84 | 1.06 | 0.22 | 0.15 |
Receivables | 6.56 | 4.87 | 2.84 | 1.06 | 0.22 | 0.15 |
Prepaid Expenses | 26.45 | 22.86 | 23.42 | 2.1 | 4.18 | 1.45 |
Total Current Assets | 570.04 | 421.69 | 474.29 | 514.17 | 76.51 | 9.64 |
Property, Plant & Equipment | 2.57 | 2.14 | 3.64 | 3.95 | 0.33 | 0.05 |
Long-Term Deferred Charges | 1.34 | 0.6 | - | - | - | - |
Other Long-Term Assets | - | - | - | 8.42 | - | - |
Total Assets | 573.95 | 424.43 | 477.93 | 526.54 | 76.84 | 9.68 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 17.04 | 0.37 | 0.18 | 0.33 | 0.16 | 0.03 |
Accrued Expenses | 24.76 | 42.79 | 20.27 | 8.07 | 7.24 | 4.76 |
Short-Term Debt | - | - | - | - | - | 15 |
Current Portion of Leases | 1.25 | 1.23 | 1.37 | 1.2 | 0.15 | - |
Current Income Taxes Payable | 2.35 | 1.09 | 0.64 | 0.37 | 0.11 | 0.06 |
Other Current Liabilities | - | - | - | - | - | 1.23 |
Total Current Liabilities | 45.39 | 45.48 | 22.46 | 9.97 | 7.67 | 21.09 |
Long-Term Debt | 99.51 | 74.1 | - | - | - | - |
Long-Term Leases | 0.77 | 0.37 | 1.46 | 2.5 | 0.13 | - |
Pension & Post-Retirement Benefits | 0.07 | - | 0.62 | 0.58 | 0.28 | 0.24 |
Total Liabilities | 145.75 | 119.95 | 24.54 | 13.05 | 8.08 | 21.33 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 |
Additional Paid-In Capital | 1,022 | 766.78 | 677.42 | 609.97 | 129.19 | 42.06 |
Retained Earnings | -594.42 | -462.91 | -235.59 | -116.66 | -80.65 | -53.64 |
Treasury Stock | - | - | - | - | - | -0.01 |
Comprehensive Income & Other | 0.63 | 0.6 | 5 | 2.36 | 0.35 | -0.17 |
Total Common Equity | 428.2 | 304.48 | 446.83 | 495.68 | 48.9 | -11.72 |
Minority Interest | - | - | 6.57 | 17.82 | 19.87 | - |
Shareholders' Equity | 428.2 | 304.48 | 453.39 | 513.49 | 68.77 | -11.65 |
Total Liabilities & Equity | 573.95 | 424.43 | 477.93 | 526.54 | 76.84 | 9.68 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 101.53 | 75.71 | 2.83 | 3.7 | 0.28 | 15 |
Net Cash (Debt) | 435.5 | 318.26 | 445.2 | 507.31 | 71.83 | -6.96 |
Net Cash Growth | 24.67% | -28.51% | -12.24% | 606.24% | - | - |
Net Cash Per Share | 6.30 | 4.94 | 7.08 | 10.33 | 2.45 | -0.89 |
Filing Date Shares Outstanding | 85.11 | 71.73 | 63.28 | 62.87 | 39.15 | 0.3 |
Total Common Shares Outstanding | 83.61 | 71.37 | 63.08 | 60.47 | 38.98 | 0.3 |
Working Capital | 524.65 | 376.22 | 451.83 | 504.2 | 68.85 | -11.45 |
Book Value Per Share | 5.12 | 4.27 | 7.08 | 8.20 | 1.25 | -38.57 |
Tangible Book Value | 428.2 | 304.48 | 446.83 | 495.68 | 48.9 | -11.72 |
Tangible Book Value Per Share | 5.12 | 4.27 | 7.08 | 8.20 | 1.25 | -38.57 |